

Prescriptions for GLP-1 medications among women with PCOS have increased more than sevenfold between 2021 and 2025, according to data from Truveta Research. This shift reflects what many women already know firsthand: PCOS weight loss isn't a matter of willpower. It's a metabolic and hormonal challenge that standard diets were never designed to solve.
Polycystic ovary syndrome affects an estimated 8% to 13% of women of reproductive age worldwide. In Singapore, where busy lifestyles leave little room for complex diet regimes and multiple clinic visits, PCOS weight loss treatment through telehealth is giving women a realistic path forward. If you've been told to "just eat less and exercise more" while dealing with insulin resistance, androgen excess, and relentless cravings, you are not alone.
This article covers why PCOS makes weight loss so difficult, how GLP-1 medications address the underlying biology, what the clinical evidence says, and how telehealth options in Singapore can help you take the next step.
If you've tried diet after diet without lasting results, it helps to understand what's actually happening in your body. PCOS disrupts several systems that directly control weight, and working against all of them at once makes conventional dieting feel impossible.
Up to 70% to 80% of women with PCOS have some degree of insulin resistance, even those at a normal weight. When your cells don't respond well to insulin, your body produces more of it to compensate. High insulin levels tell your body to store fat, particularly around the abdomen. They also make it harder to break down stored fat for energy.
This creates a frustrating cycle. You eat the same amount as someone without PCOS, but your body processes those calories differently. The excess insulin also stimulates your ovaries to produce more androgens (male hormones), which feeds back into the weight problem.
Elevated androgens, particularly testosterone, shift fat distribution towards the abdomen. This visceral fat is metabolically active and promotes further insulin resistance, creating a self-reinforcing loop. Higher androgen levels also contribute to symptoms like acne, excess hair growth, and irregular periods.
Women with PCOS often have elevated inflammatory markers. This inflammation can worsen insulin resistance and make the hypothalamus (the brain's appetite control centre) less responsive to satiety signals. The result is increased hunger and a harder time feeling full after meals.
Many women with PCOS describe constant mental chatter about food, well beyond normal hunger. This is partly driven by the hormonal disruption described above. When insulin signalling is off and inflammation affects appetite regulation, your brain genuinely receives louder and more persistent hunger signals.
It's not a lack of discipline. It's biology.
You've probably tried several approaches already. Calorie counting, keto, intermittent fasting, meal replacement shakes. These can work for people without hormonal imbalances, but for women with PCOS, the odds are stacked differently.
Severe calorie restriction can increase cortisol (stress hormone) levels, which worsens insulin resistance. It can also lower thyroid function, slowing metabolism further. For someone already dealing with PCOS-related metabolic dysfunction, aggressive dieting often backfires within weeks or months.
Regular physical activity improves insulin sensitivity and is a genuinely important part of PCOS management. But exercise alone produces modest weight loss in most studies, typically 2% to 5% of body weight. When your body is actively fighting weight loss through insulin resistance and hormonal imbalance, exercise often isn't enough on its own.
Each failed diet attempt chips away at your belief that change is possible. Many women with PCOS have lost weight before, sometimes significant amounts, only to regain it all and more. This isn't a personal failure. It reflects the biology of a condition where the metabolic deck is stacked against conventional approaches.
Research consistently shows that lifestyle modification alone produces modest results for women with PCOS. A 5% to 10% weight loss can improve symptoms meaningfully, but achieving and maintaining even that can be extremely difficult without addressing the underlying hormonal drivers.
GLP-1 (glucagon-like peptide-1) medications work by mimicking a natural hormone that regulates appetite and blood sugar. For women with PCOS, they target several of the root causes described above, not just hunger.
GLP-1 medications enhance glucose-dependent insulin secretion and suppress glucagon. This improves how your body processes blood sugar, directly addressing the insulin resistance at the heart of PCOS-related weight gain. Better insulin regulation means less signal for your body to store fat, and less stimulation of excess androgen production.
These medications act on GLP-1 receptors in the hypothalamus, activating satiety pathways (POMC/CART neurons) and inhibiting hunger pathways (NPY/AgRP neurons). They also slow gastric emptying, helping you feel full longer after meals. For women with PCOS who experience relentless cravings, this effect can be genuinely life-changing.
Emerging research suggests GLP-1 medications may have anti-inflammatory effects, which could provide additional benefit for women with PCOS-related chronic inflammation.
At Trimly, doctors prescribe both oral and injectable GLP-1 medications depending on your needs:
Here's how the main options compare:
| Medication | Format | Weight Loss (Trials) | How Often | Best For |
|---|---|---|---|---|
| Wegovy (semaglutide) | Weekly injection | 14.9% in 68 weeks (STEP 1) | Once weekly | Proven track record, strong insulin benefits |
| Mounjaro (tirzepatide) | Weekly injection | 15.0-20.9% in 72 weeks (SURMOUNT-1) | Once weekly | Higher weight loss potential, dual-action |
| Rybelsus (semaglutide) | Daily tablet | 3-5% at 14 mg dose | Daily | Patients who prefer oral medication |
Your doctor will recommend the best option based on your health profile, preferences, and goals. If you're uncomfortable with injections, oral treatment is a real option. You can read more about oral vs injectable GLP-1 formats and their respective pros and cons.
Wondering if GLP-1 treatment could help with your PCOS symptoms?
Book ConsultationWhile the large GLP-1 trials (STEP, SURMOUNT) were not PCOS-specific, a growing body of research now focuses on GLP-1 outcomes in women with polycystic ovary syndrome.
A large real-world analysis found that women with PCOS taking GLP-1 medications lost a median of 11.5% of their body weight over one year, compared to just 1.9% for those on metformin. Over half (55.7%) of GLP-1 patients achieved at least 10% weight loss, versus only 13.7% on metformin.
A 2025 study presented at ObesityWeek examined over 4,000 women with PCOS on tirzepatide. The results were striking: mean weight loss of 18.81% at 10 months, with 96.6% losing at least 5% of their body weight and 90.1% losing at least 10%.
A 2024 meta-analysis in the Journal of Diabetes and its Complications found that GLP-1 medications in women with PCOS produced:
These changes matter because excess androgens drive many of the most frustrating PCOS symptoms, including irregular periods, acne, and excess hair growth. By reducing weight and improving insulin sensitivity, GLP-1 medications can help restore hormonal balance.
Weight loss of 5% to 10% in women with PCOS has consistently been linked to improved menstrual regularity and restored ovulation. In one study examining tirzepatide in PCOS, irregular menstrual cycles decreased from 85.7% to 32.1% after treatment. This aligns with research showing that even modest weight reduction can meaningfully improve reproductive outcomes.
For a broader look at how these medications work long term, see our guide on GLP-1 for long-term weight loss.
If you are thinking about pregnancy, this is an important topic to discuss with your doctor. The relationship between GLP-1 medications, PCOS, and fertility has several dimensions.
For women with PCOS, losing weight often restores ovulation and improves the chances of natural conception. The hormonal improvements seen with GLP-1 treatment, including lower androgens and better insulin sensitivity, support this. Some researchers have noted increased pregnancy rates among women who lost weight on GLP-1 medications.
Semaglutide and tirzepatide are contraindicated during pregnancy. The manufacturers recommend stopping semaglutide at least two months before trying to conceive, to allow the medication to clear fully from your body. If you discover you are pregnant while on a GLP-1 medication, stop it immediately and contact your doctor.
Animal studies have shown potential risks during pregnancy. There isn't enough human data to confirm safety. Your doctor can help you plan a safe transition off the medication before you start trying for a baby.
Because GLP-1 medications slow gastric emptying, some experts have raised the question of whether oral contraceptive absorption could be affected. If you rely on the pill, discuss this with your doctor. Non-oral contraceptive methods (IUDs, implants, patches) are not affected.
The emotional toll of PCOS is real and often underestimated, even by doctors.
Women with PCOS have significantly higher rates of anxiety and depression compared to women without the condition. The hormonal imbalances, frustration with weight, body image concerns, and the social stigma of visible symptoms like acne and excess hair growth all contribute.
Being repeatedly told to "just lose weight" by healthcare providers, without acknowledgement of how hard that is with PCOS, can feel dismissive. Many women describe feeling unheard, blamed, or ashamed. If that has been your experience, it was not fair and it was not accurate.
When GLP-1 medications reduce food noise and hunger, many patients report a sense of mental relief that goes beyond the numbers on the scale. The constant preoccupation with food fades. Energy improves as weight decreases. Confidence starts to rebuild.
This doesn't mean medication replaces mental health support. If you are dealing with depression or anxiety alongside PCOS, working with a mental health professional can make a meaningful difference. But addressing the biological drivers of weight gain can remove one of the heaviest burdens.
For women in Singapore, telehealth has made PCOS weight loss treatment more accessible than ever. No more taking half a day off work for a clinic visit, no more awkward waiting rooms, no more repeating your story to a new doctor each time.
Trimly is an MOH-licensed telehealth clinic focused specifically on weight loss treatment. The process is straightforward:
Trimly's eligibility criteria for GLP-1 treatment include women with a BMI of 24 or above with weight-related conditions like PCOS, or a BMI of 27.5 or above without other conditions. For a woman who is 160 cm tall, a BMI of 24 is around 61 kg and a BMI of 27.5 is around 70 kg.
Plans start from $350 per month and go up to $650 per month depending on medication type and dosage. This is all-in pricing that covers:
There are no hidden fees. You can learn more about what doctors check before prescribing GLP-1 to understand the assessment process.
PCOS is a chronic condition that benefits from ongoing monitoring and dose adjustments. Telehealth makes this practical. You can check in with your doctor regularly without the friction of scheduling physical appointments. For busy professionals and mothers in Singapore, this convenience is often the difference between sticking with treatment and dropping off.
Research supports this approach. Patients who engage regularly with their treatment team, through weekly weight tracking and monthly check-ins, see better outcomes with remote monitoring.
Medication works best when paired with sustainable lifestyle changes. You don't need to overhaul your entire life. Small, consistent adjustments make a real difference.
Focus on foods that help stabilise blood sugar and reduce inflammation:
You don't need to follow a strict diet plan. The goal is consistent, balanced eating. For more detailed guidance, read about nutrition support for GLP-1 users.
Aim for 150 minutes of moderate activity per week. A mix of:
Cortisol worsens insulin resistance. Aim for 7 to 9 hours of sleep per night and consider practices like yoga, meditation, or simple breathing exercises. In Singapore's fast-paced environment, even 10 minutes of daily mindfulness can help.
For more on building sustainable habits with GLP-1 treatment, see our dedicated guide.
Yes. Clinical research shows that GLP-1 medications can reduce androgen levels, improve insulin sensitivity, and restore menstrual regularity in women with PCOS. A 2024 meta-analysis found significant reductions in total testosterone and waist circumference. Weight loss of 5% to 10% has been consistently linked to improvements in acne, excess hair growth, and ovulation. These benefits come from addressing the metabolic root causes of PCOS, not just the weight.
Results vary by individual, but real-world data shows women with PCOS losing a median of 11.5% of body weight over one year on GLP-1 medications. In the STEP 1 trial, semaglutide produced 14.9% mean weight loss over 68 weeks. Studies on tirzepatide in women with PCOS have shown even higher figures. Your doctor will set realistic expectations based on your starting point, medication choice, and overall health.
GLP-1 medications are not safe during pregnancy and must be stopped before trying to conceive. Manufacturers recommend discontinuing semaglutide at least two months before attempting conception. The good news is that weight loss from GLP-1 treatment can actually improve fertility by restoring ovulation and improving hormonal balance. Your doctor will help you plan the right timing if pregnancy is part of your future plans.
Not necessarily. Trimly's eligibility is based on BMI thresholds: BMI of 24 or above with weight-related conditions (including PCOS), or BMI of 27.5 or above without other conditions. If you suspect you have PCOS but have not been formally diagnosed, your doctor can discuss this during the consultation and factor it into your treatment plan.
Weight regain is possible if you stop treatment without having built sustainable habits. That is why Trimly's approach includes ongoing support and guidance on maintaining weight after GLP-1 treatment. The lifestyle changes you build during treatment, better eating patterns, regular movement, improved relationship with food, help protect your results long term.
PCOS weight loss is genuinely difficult. Not because of anything you have done wrong, but because of how the condition affects your metabolism, hormones, and appetite at a biological level. Recognising this is the first step toward finding an approach that actually works with your body instead of against it.
Here is what to take away:
If PCOS has made weight loss feel impossible, it doesn't have to stay that way. The science has caught up with what you have been experiencing, and effective treatment is more accessible than it has ever been.
Ready to explore GLP-1 treatment for PCOS-related weight gain?
Book Consultation